Adial
ADIL NASDAQ
2.020
+0.040
+2.02%
Closed 16:00 07/16 EDT
Open
1.990
Prev Close
1.980
High
2.150
Low
1.990
Volume
91.54K
Avg Vol (3M)
75.64K
52 Week High
9.44
52 Week Low
1.106
% Turnover
0.90%
Market Cap
20.65M
1D
5D
1M
3M
1Y
5Y
Related
VictoryShares US Small Cap Vol Wtd ETFInvesco Global Water ETFCryoportDelMar PharmaOncternal Therapeutics IncQuotientMyoKardiaAmerisafeFarmer BrosG 3 Apparl GrpLifetime BrandsSeaChange IntlUnited GuardianMarketAxessFulgent GeneticsLiberty MediaG1 TherapeuticsArrow DWA Country Rotation ETFTRIDENT ACQUISITIONSBLUE HAT INTERACTIVE ENTERTAINMENT TECHNOLOGY
Webull offers Adial ADIL stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.
Company Profile
Adial Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development of a therapeutic agent for the treatment of alcohol use disorder (AUD). Its lead drug product is AD04. AD04 is a selective serotonin-3 antagonist. AD04 can also be used for the treatment of other addictive disorders, such as obesity, smoking, and drug addiction. The Company has completed a Phase-II clinical trials of AD04.
MORE >Recently
Name
Price
%Change